Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic Cystinosis

Autor: Taranta, Anna, elmonem, mohamed a, Bellomo, Francesco, Leo, Ester De, Boenzi, Sara, Janssen, Manoe J., Jamalpoor, Amer, Cairoli, Sara, Pastore, Anna, Stefanis, Cristiano De, Colucci, Manuela, Rega, Laura R., giovannoni, isabella, Francalanci, Paola, Heuvel, Lambertus P. van den, Dionisi-Vici, Carlo, Goffredo, Bianca M., Masereeuw, Rosalinde, Levtchenko, Elena, Emma, Francesco, Afd Pharmacology, Pharmacology

Publikováno v: Cells, 10
Cells, 10(12), 1. Multidisciplinary Digital Publishing Institute (MDPI)
Cells; Volume 10; Issue 12; Pages: 3294
Cells, Vol 10, Iss 3294, p 3294 (2021)
Cells
Cells, 10, 12

Nephropathic cystinosis is a rare disease caused by mutations of the CTNS gene that encodes for cystinosin, a lysosomal cystine/H+ symporter. The disease is characterized by early-onset chronic kidney failure and progressive development of extra-rena

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd93ce0aab0f9f430f8fb0eeafadd2b2
https://lirias.kuleuven.be/handle/20.500.12942/687163